سوق التغليف الزجاجي للأدوية في الشرق الأوسط وأفريقيا – اتجاهات الصناعة والتوقعات حتى عام 2031

تحليل وحجم سوق التغليف الزجاجي للأدوية في الشرق الأوسط وأفريقيا

تشمل المنتجات الطبية مجموعة واسعة من التركيبات الصيدلانية، بما في ذلك الأقراص والكبسولات والسوائل والحقن، وكلها تتطلب تغليفًا موثوقًا به للحفاظ على فعاليتها وسلامتها. تخدم شركات التغليف الزجاجي للأدوية خيارًا مفضلًا لتخزين وتوزيع هذه المنتجات نظرًا لطبيعتها الخاملة، والتي تمنع التفاعلات الكيميائية وتحافظ على سلامة المنتج. توفر العبوات الزجاجية من سوق التغليف الزجاجي للأدوية خصائص حاجزة ممتازة، تحمي الأدوية من الرطوبة والضوء والأكسجين، وبالتالي إطالة عمرها الافتراضي.

تم تقييم حجم سوق التغليف الزجاجي للأدوية في الشرق الأوسط وأفريقيا بـ 3،23،002.47 ألف دولار أمريكي في عام 2023 ومن المتوقع أن يصل إلى 5،59،141.35 ألف دولار أمريكي بحلول عام 2031، مع معدل نمو سنوي مركب بنسبة 7.1٪ خلال الفترة المتوقعة من 2024 إلى 2031. بالإضافة إلى الرؤى حول سيناريوهات السوق مثل القيمة السوقية ومعدل النمو والتجزئة والتغطية الجغرافية واللاعبين الرئيسيين، تتضمن تقارير السوق التي تم تنظيمها بواسطة Data Bridge Market Research أيضًا تحليلًا متعمقًا من الخبراء والإنتاج والقدرة التمثيلية الجغرافية للشركة وتخطيطات الشبكة للموزعين والشركاء وتحليل مفصل ومحدث لاتجاهات الأسعار وتحليل العجز في سلسلة التوريد والطلب.         

نطاق التقرير وتقسيم السوق       

Market Definition

Pharmaceutical glass packaging refers to containers made from glass specifically designed for storing and transporting pharmaceutical products such as medicines, vaccines, and injectables. These containers, including vials, ampoules, bottles, and syringes, ensure the integrity, safety, and efficacy of the enclosed pharmaceuticals, protecting them from contamination, light, and environmental factors.

Pharmaceutical Glass Packaging Market Dynamics

Drivers

• Rising Stringent Regulations

Regulatory bodies worldwide impose strict guidelines on packaging materials to ensure the protection of medicinal products from contamination, degradation, and tampering. Glass packaging is favored for pharmaceuticals due to its inert nature, which minimizes the risk of chemical interactions and maintains product stability. Regulations also govern aspects such as sterility and barrier properties, further emphasizing the suitability of glass containers. Compliance with these regulations necessitates pharmaceutical companies to invest in reliable packaging solutions, driving the demand for pharmaceutical glass packaging and propelling the market growth.

• Growing Demand for Biopharmaceuticals

Biopharmaceuticals, including proteins, antibodies, and vaccines, often require specialized packaging to maintain stability and efficacy. Glass containers are preferred for biopharmaceuticals due to their inert and non-reactive properties, which minimize the risk of chemical interactions and degradation of sensitive biologics. In addition, glass provides excellent barrier properties, protecting biopharmaceuticals from moisture, oxygen, and light, thus extending their shelf life. As the biopharmaceutical sector continues to grow, the demand for pharmaceutical glass packaging is expected to rise, creating opportunities for glass packaging manufacturers to cater to this specialized market segment.

Opportunities

• Advancements in Drug Delivery Technologies

Glass containers offer several advantages for these innovative delivery systems, including compatibility with a wide range of drug formulations, excellent barrier properties to maintain drug stability, and inertness to prevent chemical interactions. The rise in self-administered injectable therapies and biopharmaceuticals further underscores the need for reliable and safe packaging solutions provided by pharmaceutical glass packaging. Moreover, the ability of glass to withstand extreme temperatures during sterilization processes ensures the integrity of drugs, aligning with stringent regulatory requirements. For instance, in July 2023, Corning Inc. launched Viridian Vials, a breakthrough in pharmaceutical glass packaging that aligns with the industry's focus on sustainability and efficiency. Viridian Vials' low-friction coating minimizes cracks and breaks, enhancing filling-line efficiency by up to 50%, demonstrating the impact of advancements in drug delivery technologies on the pharmaceutical glass packaging market.

• High Sustainable Packaging Preferences

Growing environmental concerns and awareness among the consumers and pharmaceutical companies increasingly favor glass packaging due to its recyclability and minimal environmental impact. Glass is a highly sustainable material, being infinitely recyclable without loss of quality, which aligns with global efforts to reduce waste and carbon footprints. Pharmaceutical glass packaging also supports sustainability goals by reducing the reliance on single-use plastics and promoting eco-friendly practices. This shift towards greener packaging solutions drives the demand for glass containers in the pharmaceutical industry, reinforcing their role as a preferred packaging material.

Restraints/Challenges

• High Production Costs for Manufacturers

Manufacturing pharmaceutical-grade glass packaging requires high-quality raw materials and advanced production technologies, leading to substantial expenses. The process involves stringent quality control measures to meet regulatory standards, further escalating costs. These high production costs can be prohibitive for smaller pharmaceutical companies, limiting their ability to adopt glass packaging. Additionally, the financial burden of maintaining and upgrading manufacturing facilities to ensure compliance with evolving regulations adds to the overall expense, impacting the market's growth potential.

• Competition from Alternative Materials

Alternative materials often offer cost advantages, greater durability, and lighter weight, making them attractive for pharmaceutical packaging. Advances in polymer technology have enhanced their barrier properties, safety features, and sustainability, further challenging the dominance of glass. The versatility and streamlined manufacturing process of plastic containers result in accelerated production timelines and reduced expenses which makes them a strong competitor against traditional glass packaging solutions. This competition pressures the glass packaging market to innovate and justify its higher costs and fragility.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Development

• In May 2023, Nipro PharmaPackaging International NV, a subsidiary of Nipro Corporation, acquired Piramida, a prominent Croatian glass pharmaceutical packaging producer. The acquisition, following Piramida's impressive growth under Blue Sea Capital's ownership, underscores Nipro's dedication to expanding its footprint in European and global pharmaceutical packaging markets
• In September 2022, Gerresheimer AG and StevanatoGroup SpA collaborated to develop a high-end ready-to-use (RTU) solution platform, focusing initially on vials using StevanatoGroup's EZ-fill technology. This partnership promises customers increased productivity, higher quality standards, faster time to market, lower total cost of ownership (TCO), and reduced supply chain risks
• In July 2022, Nipro Corporation Japan invested HRK 100 million in a new glass packaging plant in Croatia. The facility, located in Zagreb's suburb Sesvete, specializes in producing glass ampoules and vials for pharmaceuticals, aiming to meet the demand for life-saving drugs

Pharmaceutical Glass Packaging Market Scope

The market is segmented on the basis of the material, product, drug type, application, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Material

• Type I
• Type II
• Type III

Product

• Bottles
• Ampoules
• Cartridges and Syringes
• Vials
• Others

Drug Type

• Generic
• Branded
• Biologic

Application

• Oral
• Injectable
• Nasal
• Others

End-Use

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Development
• Manufacturing Companies
• Compound Pharmacy
• Others

Middle East and Africa Pharmaceutical Glass Packaging Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by material, product, drug type, application, and end-use as referenced above.

The countries covered in the market report are U.A.E., Saudi Arabia, Egypt, South Africa, Israel, Africa, and rest of Middle East and Africa.

U.A.E. is expected to dominate the market, propelled by rapid urbanization and heightened consumer awareness regarding diverse pharmaceutical glass packaging solutions. This trend reflects a burgeoning demand for advanced packaging options that ensure product safety, quality, and longevity in the rapidly expanding urban landscape of the U.A.E. With a proactive approach to meet evolving consumer needs and industry standards, the U.A.E. solidifies its position as a key player in shaping the future of pharmaceutical packaging solutions regionally and globally.

ومن المتوقع أن تشهد المملكة العربية السعودية نموًا كبيرًا في السوق بسبب ارتفاع الطلب داخل قطاع الأدوية. وتساهم عوامل مثل النمو السكاني وتوسع البنية التحتية للرعاية الصحية وزيادة إنتاج الأدوية في هذا الارتفاع. بالإضافة إلى ذلك، تعمل اللوائح الصارمة التي تشجع على استخدام عبوات عالية الجودة للأدوية على دفع السوق بشكل أكبر. ومع توسع صناعة الأدوية وابتكارها، تبرز المملكة العربية السعودية كسوق رئيسية لمصنعي عبوات الأدوية الزجاجية، مما يوفر فرصًا مربحة للنمو والاستثمار.

يقدم قسم الدولة في التقرير أيضًا عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب والاتجاهات الفنية وتحليل قوى بورتر الخمس ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. أيضًا، يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير التعريفات الجمركية المحلية وطرق التجارة أثناء تقديم تحليل تنبؤي لبيانات الدولة.

تحليل المنافسة وحصة سوق التغليف الزجاجي للأدوية

يوفر المشهد التنافسي للسوق تفاصيل حسب المنافس. وتشمل التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. وتتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة فيما يتعلق بالسوق.

بعض اللاعبين الرئيسيين العاملين في السوق هم:

• شركة راك غاني للزجاج ذ.م.م (الإمارات العربية المتحدة)
• APG (مجموعة آسيا لللب والورق) (إندونيسيا)
• شركة الشرق الأوسط للزجاج – MEG (مصر)
• بورميولي فارما سبا (إيطاليا)
• شركة فريجوجلاس (سويسرا)
• شركة الزجاج الطبي المحدودة (الصين)

SKU-65852